Literature DB >> 21796226

Active immunotherapy for the Treatment of Cocaine Dependence.

Berma M Kinsey1, Thomas R Kosten, Frank M Orson.   

Abstract

Although cocaine is illegal in most countries of the world, addiction is common and increasing in many populations, and the effectiveness of current treatment options for those afflicted has been very limited. The availability of an anti-cocaine vaccine could offer help to those who wish to quit their addiction. A number of vaccines differing in their chemical nature have been developed, and one has advanced into clinical trials. This review will discuss the successes and limitations of the various vaccines and the results of clinical trials of the vaccine using succinyl norcocaine conjugated to cholera toxin B. This latter vaccine shows considerable promise for those individuals whose antibody response is adequate..

Entities:  

Year:  2010        PMID: 21796226      PMCID: PMC3142961          DOI: 10.1358/dof.2010.035.04.1474292

Source DB:  PubMed          Journal:  Drugs Future        ISSN: 0377-8282            Impact factor:   0.148


  43 in total

1.  Intranasal lipopeptide primes lung-resident memory CD8+ T cells for long-term pulmonary protection against influenza.

Authors:  Georgia Deliyannis; Katherine Kedzierska; Yuk Fai Lau; Weiguang Zeng; Stephen J Turner; David C Jackson; Lorena E Brown
Journal:  Eur J Immunol       Date:  2006-03       Impact factor: 5.532

2.  Human therapeutic cocaine vaccine: safety and immunogenicity.

Authors:  Thomas R Kosten; Marc Rosen; Julian Bond; Michael Settles; John St Clair Roberts; John Shields; Lindsay Jack; Barbara Fox
Journal:  Vaccine       Date:  2002-01-15       Impact factor: 3.641

3.  Active cocaine immunization attenuates the discriminative properties of cocaine.

Authors:  M W Johnson; R H Ettinger
Journal:  Exp Clin Psychopharmacol       Date:  2000-05       Impact factor: 3.157

Review 4.  From cocaine to ropivacaine: the history of local anesthetic drugs.

Authors:  Y A Ruetsch; T Böni; A Borgeat
Journal:  Curr Top Med Chem       Date:  2001-08       Impact factor: 3.295

5.  An engineered cocaine hydrolase blunts and reverses cardiovascular responses to cocaine in rats.

Authors:  Yang Gao; Stephen Brimijoin
Journal:  J Pharmacol Exp Ther       Date:  2004-04-20       Impact factor: 4.030

Review 6.  Vaccines for cocaine abuse.

Authors:  Frank M Orson; Berma M Kinsey; Rana A K Singh; Yan Wu; Thomas R Kosten
Journal:  Hum Vaccin       Date:  2009-04-20

7.  Expression and characterization of a humanized cocaine-binding antibody.

Authors:  El-Rashdy M Redwan; Nicholas A Larsen; Bin Zhou; Peter Wirsching; Kim D Janda; Ian A Wilson
Journal:  Biotechnol Bioeng       Date:  2003-06-05       Impact factor: 4.530

Review 8.  New developments in the pharmacotherapy of cocaine abuse.

Authors:  Antonio Preti
Journal:  Addict Biol       Date:  2007-06       Impact factor: 4.280

9.  A second-generation vaccine protects against the psychoactive effects of cocaine.

Authors:  M R Carrera; J A Ashley; P Wirsching; G F Koob; K D Janda
Journal:  Proc Natl Acad Sci U S A       Date:  2001-02-06       Impact factor: 11.205

10.  Design of cocaethylene and cocaine conjugates to produce highly selective polyclonal antibodies.

Authors:  Caroline Gadjou; Yannic Danger; Pierre Sandouk; Jean-Michel Scherrmann; Dominique Blanchard; Gilles Folléa; Hervé Galons
Journal:  Int J Biomed Sci       Date:  2006-02
View more
  3 in total

1.  Intermittent cocaine self-administration produces sensitization of stimulant effects at the dopamine transporter.

Authors:  Erin S Calipari; Mark J Ferris; Cody A Siciliano; Benjamin A Zimmer; Sara R Jones
Journal:  J Pharmacol Exp Ther       Date:  2014-02-24       Impact factor: 4.030

2.  Hapten optimization for cocaine vaccine with improved cocaine recognition.

Authors:  Muthu Ramakrishnan; Berma M Kinsey; Rana A Singh; Thomas R Kosten; Frank M Orson
Journal:  Chem Biol Drug Des       Date:  2014-07-29       Impact factor: 2.817

3.  Combined cocaine hydrolase gene transfer and anti-cocaine vaccine synergistically block cocaine-induced locomotion.

Authors:  Marilyn E Carroll; Natalie E Zlebnik; Justin J Anker; Thomas R Kosten; Frank M Orson; Xiaoyun Shen; Berma Kinsey; Robin J Parks; Yang Gao; Stephen Brimijoin
Journal:  PLoS One       Date:  2012-08-17       Impact factor: 3.240

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.